TargetMol

CP-690550A

Product Code:
 
TAR-T31074
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31074-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31074-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31074-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.
CAS:
1243290-37-0
Formula:
C15H21N5O2
Molecular Weight:
303.366
Purity:
0.98
SMILES:
C[C@@H]1CCN(C[C@@H]1N(C)c1ncnc2[nH]ccc12)C(=O)CO

References

1. Yamaoka K. Relation between disease modifying anti-rheumatic drugs and herpes zoster in rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(3):181-9. doi: 10.2177/jsci.39.181. PubMed PMID: 27320933. 2. Radominski SC, Cardiel MH, Citera G, Goecke A, Jaller JJ, Lomonte AB, Miranda P, Velez P, Xibill? D, Kwok K, Rojo R, Garc?a EG. Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies. Reumatol Clin. 2016 Jun 14. pii: S1699-258X(16)30040-7. doi: 10.1016/j.reuma.2016.04.010. [Epub ahead of print] English, Spanish. PubMed PMID: 27317492. 3. Tanaka Y. [Tofacitinib for the treatment of rheumatoid arthritis]. Nihon Rinsho. 2016 Jun;74(6):974-80. Japanese. PubMed PMID: 27311188. 4. Sterba Y, Ilowite N. Biologics in Pediatric Rheumatology: Quo Vadis? Curr Rheumatol Rep. 2016 Jul;18(7):45. doi: 10.1007/s11926-016-0593-9. Review. PubMed PMID: 27306623.